Advanced Biomed is trading at $9.70 (10.9% down) as the stock sees a reversal of the momentum generated by its recently canceled securities offering.
- The decline follows several days of sharp volatility and profit-taking after the company decided to scrap a planned SEC-registered share offering.
- The stock is experiencing a momentum reversal following the earlier rally triggered by the cancellation news.
- No new company-specific developments have emerged after the regular close to explain the continued downward pressure.